{"meta":{"query_hash":"47f3a50fd825","filters":{"venue":"Molecular Therapy — Oncolytics"},"cohort_total":44,"direct_labels_cover":0,"predictions_cover":44,"exported":44,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/47f3a50fd825","api":"https://metacan.xera.ac/api/v1/cohort?venue=Molecular+Therapy+%E2%80%94+Oncolytics"},"results":[{"id":"W2315750663","doi":"10.1038/mto.2015.4","title":"Enhanced efficacy with azacytidine and oncolytic BHV-1 in a tolerized cotton rat model of breast adenocarcinoma","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"McMaster University; Canadian Cancer Society Research Institute; Cancer Research Society; Breast Cancer Alliance; Cancer Research Institute","keywords":"Oncolytic virus; Cancer research; Biology; Breast cancer; In vivo; Oncolytic adenovirus; Cancer; Cytotoxicity; Cancer cell; Adenocarcinoma; Immunology; Immune system; In vitro","score_opus":0.029029646094145056,"score_gpt":0.29353872021829164,"score_spread":0.2645090741241466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315750663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910176,0.002541411,0.0048891716,0.00022835158,0.000035417175,0.0008920139,0.000022765105,0.000018854615,0.00035444653],"genre_scores_gemma":[0.9972107,0.000501815,0.0014283174,0.00035331043,0.000055442157,0.00006932375,0.000055256627,0.00009303374,0.00023283521],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977891,0.0001986502,0.00042255202,0.000593471,0.00049851264,0.00049775175],"domain_scores_gemma":[0.9984989,0.000027845088,0.00016165494,0.00073839555,0.0002851458,0.00028804372],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000489782,0.00036560034,0.00049905194,0.00016241465,0.00004081289,0.00003553414,0.00036854926,0.00023011373,0.000008546756],"category_scores_gemma":[0.000049159968,0.00032575033,0.00009667873,0.00035434117,0.0002667257,0.000010700953,0.00012565561,0.00022393634,0.00000436028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01497874,0.00041636277,0.00037183095,0.000022493221,0.00010494807,0.000032538584,0.00048281293,0.008346444,0.9712471,0.00003343905,0.000034614328,0.0039286786],"study_design_scores_gemma":[0.013356071,0.007589738,0.00024054137,0.00006226899,0.000025350551,0.0000514828,0.00018337653,0.009933101,0.9678646,0.00011436827,0.00014773627,0.00043139528],"about_ca_topic_score_codex":0.00003366027,"about_ca_topic_score_gemma":0.000116377545,"teacher_disagreement_score":0.007173375,"about_ca_system_score_codex":0.00010411661,"about_ca_system_score_gemma":0.00075463083,"threshold_uncertainty_score":0.9999195},"labels":[],"label_agreement":null},{"id":"W2316138506","doi":"10.1038/mto.2016.5","title":"N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Alberta Children's Hospital; Ontario Institute for Cancer Research; Alberta Cancer Foundation; University of Calgary","funders":"Cancer Research Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Vesicular Stomatitis; Neuroblastoma; Virology; Cancer research; Vesicular stomatitis Indiana virus; Virus; Biology; Cell culture; Genetics","score_opus":0.008328318019166765,"score_gpt":0.2785129837965683,"score_spread":0.2701846657774015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316138506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99459624,0.0018145387,0.0019942783,0.00021524639,0.0001658716,0.0009863104,0.000013871746,0.000024005665,0.00018964586],"genre_scores_gemma":[0.9968866,0.0016949811,0.00018286273,0.00053712254,0.000120937184,0.000148526,0.000009418905,0.00009183691,0.00032771454],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9971807,0.0006202314,0.00049575756,0.00057261717,0.00057730754,0.000553407],"domain_scores_gemma":[0.99824387,0.00015508063,0.00023434906,0.0011127521,0.0001265334,0.00012743552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004868038,0.0003631502,0.00037988077,0.00014116598,0.00012441896,0.000035123558,0.0008087747,0.00024322189,0.00004342543],"category_scores_gemma":[0.000087877444,0.00023446296,0.00023222083,0.00030430008,0.0003208037,0.000011992818,0.00018213646,0.00019425177,0.000023397377],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070177345,0.0003150545,0.000046427267,0.000045364923,0.000075119984,0.00007199247,0.00011289883,0.00012573313,0.9884609,0.000026182715,0.00026968235,0.009748861],"study_design_scores_gemma":[0.002601083,0.005079038,0.00033573285,0.00018453313,0.000013468837,0.0000064414685,0.000019191559,0.000030409099,0.9877982,0.00020684209,0.0034182756,0.00030675138],"about_ca_topic_score_codex":0.00002790336,"about_ca_topic_score_gemma":0.000116380485,"teacher_disagreement_score":0.00944211,"about_ca_system_score_codex":0.000077293946,"about_ca_system_score_gemma":0.00018082539,"threshold_uncertainty_score":0.9561122},"labels":[],"label_agreement":null},{"id":"W2412847484","doi":"10.1038/mto.2016.1","title":"Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; BC Cancer Agency; University of British Columbia; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Vesicular stomatitis virus; Oncolytic virus; Virology; Interferon; Stomatitis; Vesicular Stomatitis; Vesicular stomatitis Indiana virus; Virus; Medicine; Cancer research; Internal medicine","score_opus":0.03397533768895688,"score_gpt":0.3126975296336064,"score_spread":0.27872219194464953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412847484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150301,0.002703461,0.079315186,0.00081445696,0.00026271734,0.00083785667,0.000036635138,0.000101586906,0.00089795643],"genre_scores_gemma":[0.99476665,0.0014835756,0.00060789974,0.0013419836,0.00029829622,0.00018856688,0.000024103885,0.00019989249,0.0010890358],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963078,0.0005641697,0.0004617604,0.0009961004,0.0007181067,0.00095207174],"domain_scores_gemma":[0.99757814,0.00008560962,0.00024347026,0.001542849,0.00024405819,0.00030587768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056264404,0.0006053626,0.00050612586,0.0001676479,0.0002948219,0.00019179368,0.00086371705,0.00041137772,0.00026203762],"category_scores_gemma":[0.00008696144,0.00047764063,0.00037853981,0.00028530348,0.00046979476,0.00003029221,0.00023157026,0.00027878903,0.00016016088],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026479708,0.00030789833,0.000028439132,0.00001424578,0.00030667422,0.000038016988,0.00010255781,0.00004401195,0.8199221,0.000023167373,0.00023310138,0.17633182],"study_design_scores_gemma":[0.0033354429,0.005782789,0.00014688962,0.000103246864,0.000030260413,0.000020670755,0.000026695747,0.000117903786,0.9704675,0.00028228562,0.019012338,0.00067399],"about_ca_topic_score_codex":0.00002445845,"about_ca_topic_score_gemma":0.00008972542,"teacher_disagreement_score":0.17565782,"about_ca_system_score_codex":0.0002679801,"about_ca_system_score_gemma":0.0005280696,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W2416659570","doi":"10.1038/mto.2015.14","title":"Chimeric antigen receptor–engineered T cells as oncolytic virus carriers","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Chimeric antigen receptor; Adoptive cell transfer; Virus; Immune system; Antigen; Cancer research; Antibody; Immunology; Receptor; Biology; Immunotherapy; Virology; T cell","score_opus":0.035945221340119994,"score_gpt":0.3239435815978033,"score_spread":0.2879983602576833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416659570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9718275,0.003859696,0.001428251,0.001025307,0.0009406494,0.00202627,0.000027839973,0.0003198254,0.018544646],"genre_scores_gemma":[0.95075554,0.004485335,0.005495506,0.0054790997,0.0009332865,0.0001742706,0.00016077815,0.000538556,0.031977605],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99613225,0.00021379947,0.0005525968,0.00066331733,0.0014989367,0.0009390952],"domain_scores_gemma":[0.99694407,0.0000905372,0.00014315457,0.0012275871,0.00043900934,0.0011556306],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0007241262,0.0005275937,0.0008027705,0.0003502809,0.00010344715,0.000101747995,0.00046583242,0.0003557764,0.0027640134],"category_scores_gemma":[0.00016210675,0.00050102436,0.00038158675,0.0010444215,0.00023036807,0.00009852896,0.0000961583,0.00069815613,0.0011878733],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000882598,0.0004280802,0.00023490559,0.00002991113,0.00049622287,0.0005312213,0.0011907878,0.00033632832,0.962043,0.00007633386,0.005524746,0.028225904],"study_design_scores_gemma":[0.00501947,0.0018199303,0.000070570604,0.000048144226,0.00005705622,0.00009332135,0.00036294688,0.0008488349,0.62851584,0.00012575535,0.36261034,0.000427776],"about_ca_topic_score_codex":0.00041689817,"about_ca_topic_score_gemma":0.000008710991,"teacher_disagreement_score":0.3570856,"about_ca_system_score_codex":0.00093411416,"about_ca_system_score_gemma":0.0014273454,"threshold_uncertainty_score":0.9997441},"labels":[],"label_agreement":null},{"id":"W2468950574","doi":"10.1038/mto.2016.17","title":"Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke","keywords":"Genetic enhancement; Cancer research; Adeno-associated virus; Brain tumor; Biology; Reporter gene; Systemic administration; Transgene; Viral vector; Gene delivery; Vector (molecular biology); Immunology; Pathology; Molecular biology; Gene; Gene expression; Medicine; In vivo; Recombinant DNA","score_opus":0.021114307487250156,"score_gpt":0.2848859474876812,"score_spread":0.2637716400004311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2468950574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390274,0.0012168417,0.0027924771,0.0004624542,0.00010405209,0.001156764,0.000058804006,0.000043871536,0.00026200805],"genre_scores_gemma":[0.9963732,0.0008328081,0.00067737006,0.0013184252,0.00006873003,0.00022795623,0.000035017736,0.00011930069,0.0003471927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99688923,0.0003640755,0.0006326996,0.00079281454,0.00054009026,0.000781112],"domain_scores_gemma":[0.9981538,0.000049788923,0.0002020266,0.001067639,0.00023928436,0.0002874606],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030023456,0.00045573848,0.00044413417,0.00019544225,0.00008418525,0.000058291615,0.00063939317,0.00039889975,0.000039782713],"category_scores_gemma":[0.00012207733,0.00036885648,0.0002516973,0.00028579176,0.00021659162,0.000012339376,0.00019539752,0.00021039024,0.000042594693],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038664008,0.00031249624,0.00035108777,0.000036977224,0.00014531246,0.00018223395,0.0001904497,0.00027433355,0.9823467,0.000035226894,0.00012242903,0.012136316],"study_design_scores_gemma":[0.0047620144,0.007747246,0.00007396526,0.00017303812,0.000011808797,0.000042146734,0.000072224095,0.00040381905,0.9846796,0.00022934335,0.0012789839,0.0005258548],"about_ca_topic_score_codex":0.000008965772,"about_ca_topic_score_gemma":0.0003227484,"teacher_disagreement_score":0.0116104605,"about_ca_system_score_codex":0.00014534629,"about_ca_system_score_gemma":0.00066792534,"threshold_uncertainty_score":0.9998763},"labels":[],"label_agreement":null},{"id":"W2469820651","doi":"10.1038/mto.2015.13","title":"Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis","year":2015,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; Ovarian Cancer Canada; Cancer Care Ontario; Western University","funders":"","keywords":"Oncolytic virus; Myxoma virus; Ovarian cancer; Virus; Biology; Metastasis; Vaccinia; Cancer research; Cancer cell; Virology; Spheroid; Cell culture; Cancer","score_opus":0.12241179232364242,"score_gpt":0.3962003653944838,"score_spread":0.27378857307084137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2469820651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98649997,0.0021700829,0.009569941,0.00022811398,0.00011353363,0.0012537031,0.00012957263,0.000011573276,0.00002350597],"genre_scores_gemma":[0.99551463,0.00059605786,0.002879098,0.00032382098,0.00014890259,0.00029541866,0.00008742165,0.00008749979,0.000067123285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974111,0.00034640444,0.00055432424,0.0006200133,0.00048461516,0.0005835703],"domain_scores_gemma":[0.9985557,0.000056365327,0.00015968886,0.0007422232,0.00025842636,0.00022760074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008338907,0.00032765866,0.0004953869,0.00022663218,0.000035982008,0.000039827155,0.00063288346,0.000262389,0.000011974405],"category_scores_gemma":[0.00018207573,0.00032417756,0.00020912634,0.00028408007,0.00013795921,0.000019803807,0.00010777279,0.00021633437,0.0000018580174],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02195953,0.00080629403,0.00016495134,0.000023421026,0.00009011028,0.000009858471,0.00029119127,0.027303804,0.92171,0.000027268128,0.00001920175,0.027594341],"study_design_scores_gemma":[0.008520373,0.0043465025,0.00012223388,0.000052307907,0.000029171371,0.0000014370114,0.000043650954,0.048305493,0.9377708,0.00031360806,0.00015118421,0.0003432524],"about_ca_topic_score_codex":0.0001596839,"about_ca_topic_score_gemma":0.00060394366,"teacher_disagreement_score":0.027251089,"about_ca_system_score_codex":0.000219448,"about_ca_system_score_gemma":0.0010762337,"threshold_uncertainty_score":0.999921},"labels":[],"label_agreement":null},{"id":"W2550160905","doi":"10.1038/mto.2016.27","title":"Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies","year":2016,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Viral Infections and Outbreaks Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Children's Hospital of Eastern Ontario; University of Toronto; University Health Network; Ottawa Hospital; University of Ottawa; Ontario Institute for Cancer Research","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Lymphocytic choriomeningitis; Virology; Antibody; Virus; Biology; Neutralizing antibody; Arenavirus; Glycoprotein; Oncolytic virus; Immune system; Neutralization; Immunology; Molecular biology","score_opus":0.043154517025019004,"score_gpt":0.33702531308301475,"score_spread":0.29387079605799576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2550160905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99617565,0.00045614876,0.001128119,0.00050942885,0.000022363933,0.00077575987,0.00002777323,0.00001178483,0.0008929915],"genre_scores_gemma":[0.9986807,0.0004692008,0.00041369034,0.00025470834,0.000028166409,0.000031402866,0.00000444272,0.000014996507,0.00010269304],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99864817,0.00017426674,0.0003571721,0.00016307115,0.00043865753,0.00021864101],"domain_scores_gemma":[0.9992217,0.00012963527,0.00012377105,0.00029821455,0.00019701765,0.000029683953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004390843,0.00012363496,0.00027953341,0.00016422787,0.000043147513,0.000011247945,0.00011053588,0.00004536453,0.00010596403],"category_scores_gemma":[0.00007284824,0.00006869105,0.00010678584,0.00030435948,0.0002354889,0.00007465748,0.00004884898,0.000106325606,0.000011588452],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059157546,0.0004792501,0.007391607,0.00007771437,0.000053720512,0.00008040935,0.0002032836,0.0000069231037,0.9782661,0.00063324923,0.00012983801,0.012086319],"study_design_scores_gemma":[0.0024971203,0.0016187528,0.008628198,0.00040407537,0.000018810939,0.000018929615,0.0002162099,0.00012899187,0.98370916,0.00033300792,0.0023317547,0.00009499156],"about_ca_topic_score_codex":0.00036205654,"about_ca_topic_score_gemma":0.000047987018,"teacher_disagreement_score":0.011991327,"about_ca_system_score_codex":0.00005320266,"about_ca_system_score_gemma":0.00012337911,"threshold_uncertainty_score":0.28011397},"labels":[],"label_agreement":null},{"id":"W2744993513","doi":"10.1016/j.omto.2017.08.001","title":"Reovirus FAST Protein Enhances Vesicular Stomatitis Virus Oncolytic Virotherapy in Primary and Metastatic Tumor Models","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University; University of Ottawa","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Beatrice Hunter Cancer Research Institute","keywords":"Oncolytic virus; Virotherapy; Vesicular stomatitis virus; Virology; Vesicular Stomatitis; Virus; Biology; Cancer research; Medicine","score_opus":0.023725987008250304,"score_gpt":0.30508686484796516,"score_spread":0.28136087783971486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2744993513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98641044,0.0064498987,0.0033259445,0.00036155232,0.00008504297,0.002011999,0.000050925755,0.00003804024,0.0012661485],"genre_scores_gemma":[0.99107635,0.0034409673,0.0025357502,0.0015219214,0.00013188907,0.0005131833,0.00004963693,0.00017322553,0.0005570633],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99653375,0.000414094,0.0005946742,0.0009731144,0.000683005,0.00080133294],"domain_scores_gemma":[0.9974384,0.000030125282,0.00037661687,0.0017500555,0.0001420542,0.00026279775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009004839,0.0005710782,0.00064801937,0.00020039843,0.000412001,0.00032120067,0.0010252119,0.0002115812,0.00003923985],"category_scores_gemma":[0.00008210221,0.0005630788,0.00020317557,0.00016289979,0.0005016775,0.000055761,0.0002574428,0.00037510434,0.000023317862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020339475,0.00037034834,0.00013474327,0.0000613753,0.00022141516,0.00028396124,0.00016538549,0.000411914,0.9652809,0.00011053916,0.00004137103,0.030884102],"study_design_scores_gemma":[0.0047593685,0.004116955,0.00077560626,0.00012045439,0.000020673862,0.00004193168,0.000053067062,0.0018922568,0.983131,0.0015281799,0.0028244546,0.0007360784],"about_ca_topic_score_codex":0.00019938646,"about_ca_topic_score_gemma":0.0005669834,"teacher_disagreement_score":0.030148024,"about_ca_system_score_codex":0.0001665835,"about_ca_system_score_gemma":0.00049629965,"threshold_uncertainty_score":0.99968207},"labels":[],"label_agreement":null},{"id":"W2756406213","doi":"10.1016/j.omto.2017.09.004","title":"Activating Peripheral Innate Immunity Enables Safe and Effective Oncolytic Virotherapy in the Brain","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Wilfrid Laurier University; Ottawa Hospital; Children's Hospital of Eastern Ontario","funders":"National Cancer Institute","keywords":"Oncolytic virus; Vesicular stomatitis virus; Virus; Virotherapy; Medicine; Immunology; Immune system; Virology","score_opus":0.01909480124259364,"score_gpt":0.32994100818512667,"score_spread":0.310846206942533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756406213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917624,0.0022007246,0.00053222955,0.0021534534,0.000077530494,0.0014370651,0.000011420691,0.000015657059,0.001809529],"genre_scores_gemma":[0.9941995,0.001410294,0.00031766578,0.0032539703,0.00018062614,0.00024899698,0.000024172325,0.00008520472,0.00027954095],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972183,0.00088577654,0.00031851235,0.00055988354,0.00041745653,0.00060008414],"domain_scores_gemma":[0.9978934,0.00015258804,0.00022352941,0.0015258545,0.00009663766,0.00010800159],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016939692,0.00039155493,0.00034539038,0.00009648495,0.0007339141,0.0003665407,0.0011163077,0.0002688793,0.000026367834],"category_scores_gemma":[0.0003316505,0.00031218084,0.00014966803,0.00014691411,0.00045885402,0.000024407273,0.00021904589,0.0005259848,0.000005169435],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023689512,0.00022283962,0.0016849156,0.000017218406,0.00015278345,0.000052336225,0.0008570284,0.00011488085,0.8845334,0.00008642352,0.0001028147,0.10980642],"study_design_scores_gemma":[0.0077155638,0.007659622,0.01986243,0.00008072121,0.0000139552185,0.00005300681,0.0006044887,0.0006771836,0.92632586,0.0010521227,0.035160434,0.00079464074],"about_ca_topic_score_codex":0.0001696657,"about_ca_topic_score_gemma":0.00034570863,"teacher_disagreement_score":0.10901178,"about_ca_system_score_codex":0.000109451,"about_ca_system_score_gemma":0.00020257644,"threshold_uncertainty_score":0.999933},"labels":[],"label_agreement":null},{"id":"W2756920003","doi":"10.1016/j.omto.2017.08.004","title":"Infectious Optimism following the 10th International Oncolytic Virus Meeting","year":2017,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Ottawa Hospital; McMaster University","funders":"","keywords":"Oncolytic virus; Optimism; Commercialization; Coronavirus disease 2019 (COVID-19); Medicine; Political science; Virus; Virology; Psychology; Infectious disease (medical specialty); Pathology","score_opus":0.022831408473286168,"score_gpt":0.3364568364062731,"score_spread":0.3136254279329869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2756920003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97912705,0.00150648,0.001730973,0.0016794144,0.0009159448,0.0006296525,0.000013441619,0.000046763525,0.0143502625],"genre_scores_gemma":[0.9940464,0.0012435113,0.0004998566,0.0019746597,0.00060239545,0.00009726016,0.000042114392,0.000107722844,0.00138609],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976913,0.0001994902,0.00034593052,0.0005662825,0.0006408879,0.0005561386],"domain_scores_gemma":[0.99763393,0.00004328099,0.00027578927,0.0017172706,0.00017768283,0.00015201495],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00095696823,0.00034350817,0.0002573149,0.00007921308,0.0009300334,0.0004879362,0.0017318957,0.00024092349,0.00005502402],"category_scores_gemma":[0.00034799983,0.00028210197,0.00040337446,0.000088804925,0.00023639112,0.000017673283,0.00042208706,0.00034982755,0.0000608331],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007355232,0.00017051904,0.0009116921,0.000004832904,0.0006266292,0.000096415024,0.00013847709,0.0014005445,0.9658993,0.00007444038,0.0006176521,0.029324],"study_design_scores_gemma":[0.003248391,0.0020102577,0.00042360352,0.000040198163,0.00004281756,0.00003762279,0.000071419454,0.0015214778,0.9090079,0.0003823767,0.08267314,0.00054075674],"about_ca_topic_score_codex":0.00009650249,"about_ca_topic_score_gemma":0.00021534598,"teacher_disagreement_score":0.08205549,"about_ca_system_score_codex":0.00012172075,"about_ca_system_score_gemma":0.00028407684,"threshold_uncertainty_score":0.9999631},"labels":[],"label_agreement":null},{"id":"W2801932471","doi":"10.1016/j.omto.2018.04.002","title":"Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Deutsche Krebshilfe","keywords":"Oncolytic virus; Measles virus; Virology; Measles; microRNA; Virus; Medicine; Biology; Vaccination; Gene; Genetics","score_opus":0.02540920253507335,"score_gpt":0.32057624237234045,"score_spread":0.2951670398372671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801932471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93963957,0.0039895354,0.05479648,0.00009430692,0.00014518958,0.00068050233,0.00006818375,0.000027588183,0.00055867294],"genre_scores_gemma":[0.99376804,0.0004350467,0.0037778527,0.0012078912,0.0004143351,0.000029539135,0.00005071004,0.00011703262,0.00019954456],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974299,0.0002953303,0.0005208486,0.00060407334,0.0005143533,0.000635474],"domain_scores_gemma":[0.9979603,0.000036931793,0.00026928794,0.0009511621,0.0005884873,0.00019379577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005429495,0.00039258832,0.0004774302,0.00014659374,0.00015321889,0.00004553365,0.0006217998,0.0003090459,0.00016260543],"category_scores_gemma":[0.00011108796,0.00038644424,0.0002907045,0.0003355029,0.0005144997,0.000008576063,0.00010825298,0.00018558148,0.000042423108],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038865372,0.00028562816,0.00014827125,0.000019190311,0.00038989304,0.00001280182,0.000120749704,0.0004433197,0.9911363,0.000027141423,0.00012405169,0.0034060793],"study_design_scores_gemma":[0.003300811,0.0061552613,0.000037966347,0.00002822497,0.000037539063,0.000011426118,0.000041543935,0.0018411475,0.9824135,0.00018992287,0.0055337204,0.0004089664],"about_ca_topic_score_codex":0.00002987321,"about_ca_topic_score_gemma":0.00007307911,"teacher_disagreement_score":0.054128505,"about_ca_system_score_codex":0.00009370855,"about_ca_system_score_gemma":0.0004826503,"threshold_uncertainty_score":0.99985874},"labels":[],"label_agreement":null},{"id":"W2809465143","doi":"10.1016/j.omto.2018.06.002","title":"Combination of IAP Antagonists and TNF-α-Armed Oncolytic Viruses Induce Tumor Vascular Shutdown and Tumor Regression","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Health Canada; Fondation Brain Canada; Cancer Research Institute; Ocean Reef Community Foundation","keywords":"Oncolytic virus; Vesicular stomatitis virus; Tumor necrosis factor alpha; Proinflammatory cytokine; Medicine; Inhibitor of apoptosis; Cancer research; Immunology; Innate immune system; Apoptosis; Cytokine; Immune system; Cancer; Programmed cell death; Virology; Virus; Biology; Inflammation; Internal medicine","score_opus":0.022894667437807166,"score_gpt":0.32186215139592295,"score_spread":0.2989674839581158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809465143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377406,0.0043767877,0.00046300745,0.00020762268,0.00012473609,0.0007481095,0.000022056533,0.000027250864,0.0002563733],"genre_scores_gemma":[0.995993,0.0014026759,0.0008879488,0.001286456,0.00016019448,0.000046477355,0.000038709106,0.00008929627,0.000095222036],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975918,0.00030797598,0.0004428104,0.00066750584,0.00052943337,0.00046046093],"domain_scores_gemma":[0.9983665,0.000042926044,0.0002509325,0.00074746687,0.00036854102,0.00022364223],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066327193,0.00037909785,0.00042719513,0.00016916636,0.00020714565,0.000074144395,0.0003402308,0.0002061134,0.000032514843],"category_scores_gemma":[0.00014025319,0.0003440712,0.00012535394,0.00028774978,0.00068594515,0.000015807409,0.00021604648,0.00021335763,0.000008391579],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017906829,0.00029396248,0.0011175864,0.00005368239,0.00017891431,0.0000308889,0.00018168778,0.0000053028566,0.98175436,0.00008808347,0.00021621234,0.014288638],"study_design_scores_gemma":[0.0035737092,0.0077815503,0.0014953665,0.000084911226,0.00003827292,0.000045724733,0.00009744771,0.00036394258,0.975577,0.00033075936,0.010215648,0.00039568671],"about_ca_topic_score_codex":0.00003114685,"about_ca_topic_score_gemma":0.000041957082,"teacher_disagreement_score":0.0138929505,"about_ca_system_score_codex":0.000058603255,"about_ca_system_score_gemma":0.00029958042,"threshold_uncertainty_score":0.9999011},"labels":[],"label_agreement":null},{"id":"W2882978751","doi":"10.1016/j.omto.2018.06.001","title":"Visualizing Oncolytic Virus-Host Interactions in Live Mice Using Intravital Microscopy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"Canadian Cancer Society Research Institute; U.S. Food and Drug Administration; Alberta Children's Hospital Foundation; Canada Research Chairs","keywords":"Oncolytic virus; Vesicular stomatitis virus; Intravital microscopy; Virus; Biology; Context (archaeology); Spleen; Virology; Alexa Fluor; Cell biology; In vivo; Immunology","score_opus":0.03640351332765523,"score_gpt":0.39077307762313984,"score_spread":0.3543695642954846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2882978751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922312,0.0013053936,0.0046675047,0.00012202902,0.0003828256,0.0006833065,0.00004418401,0.000033941727,0.00052961806],"genre_scores_gemma":[0.99419963,0.00045142276,0.0024364095,0.0017902048,0.00058067346,0.000046627967,0.000069973255,0.00014401488,0.00028101465],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997206,0.00031778944,0.00051571726,0.00074425945,0.0003765794,0.0008396524],"domain_scores_gemma":[0.9985566,0.00004173516,0.00016844679,0.0007418084,0.0002881995,0.0002032227],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005476545,0.0004155852,0.0003509839,0.00026732223,0.00025576074,0.00012800323,0.0005510476,0.00022899907,0.00017102998],"category_scores_gemma":[0.000090363385,0.0004535279,0.00019855986,0.0005087564,0.00030263577,0.00002010138,0.00021732503,0.00039620665,0.00014739926],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022791466,0.00048459822,0.00039362512,0.0000114797085,0.00014663507,0.000056572662,0.00064255844,0.000089152374,0.99332464,0.000021707709,0.00017015715,0.002379703],"study_design_scores_gemma":[0.0022393074,0.003607416,0.00016690785,0.00007410462,0.000019585983,0.000046584577,0.00039680485,0.0020409576,0.976041,0.00005624346,0.014800077,0.0005109654],"about_ca_topic_score_codex":0.00019676944,"about_ca_topic_score_gemma":0.0018392781,"teacher_disagreement_score":0.017283618,"about_ca_system_score_codex":0.0003048437,"about_ca_system_score_gemma":0.00047994286,"threshold_uncertainty_score":0.9997916},"labels":[],"label_agreement":null},{"id":"W2888927593","doi":"10.1016/j.omto.2018.08.003","title":"APOBEC3 Mediates Resistance to Oncolytic Viral Therapy","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Oncolytics Biotech; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Rosetrees Trust; Richard M. Schulze Family Foundation; Mayo Foundation for Medical Education and Research; University of Minnesota; Mayo Clinic","keywords":"Oncolytic virus; Vesicular stomatitis virus; Biology; Virotherapy; Gene knockdown; Virology; Virus; Cancer cell; Interferon; Cancer research; Cell culture; Cancer; Genetics","score_opus":0.0205703581799672,"score_gpt":0.3219701523271543,"score_spread":0.3013997941471871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888927593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98527825,0.004722773,0.0022992091,0.0015671416,0.00037840265,0.001220912,0.000036405203,0.00008848257,0.0044084205],"genre_scores_gemma":[0.979514,0.002036559,0.0025432026,0.009587049,0.0012815985,0.0002103393,0.00008379444,0.00021703569,0.0045264326],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99643594,0.00032059147,0.0004904727,0.0009780129,0.00079524494,0.000979713],"domain_scores_gemma":[0.997361,0.000043222535,0.00014070672,0.0015233529,0.00048314835,0.00044858785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007534863,0.0005298629,0.00042138703,0.00019547889,0.0002769008,0.00012898182,0.0010672144,0.00034739272,0.00022376768],"category_scores_gemma":[0.00014045398,0.0005034814,0.00026969818,0.0005567357,0.00037621826,0.00001080865,0.00019171894,0.00026746266,0.00042751146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0065687653,0.0002711995,0.0001580846,0.000008447995,0.00022103824,0.000034875506,0.0002529909,0.00004788092,0.9652041,0.00011050424,0.0065254276,0.02059669],"study_design_scores_gemma":[0.0021374093,0.007932242,0.00014637689,0.000020465412,0.000008096346,0.0000059809163,0.000034952223,0.0000418707,0.7442215,0.00040699574,0.24454528,0.0004988066],"about_ca_topic_score_codex":0.000016246646,"about_ca_topic_score_gemma":0.00029473545,"teacher_disagreement_score":0.23801985,"about_ca_system_score_codex":0.00014165163,"about_ca_system_score_gemma":0.0004898288,"threshold_uncertainty_score":0.9997417},"labels":[],"label_agreement":null},{"id":"W2892207721","doi":"10.1016/j.omto.2018.09.002","title":"Glioblastoma Bystander Cell Therapy: Improvements in Treatment and Insights into the Therapy Mechanisms","year":2018,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red en Bioingeniería, Biomateriales y Nanomedicina; Consejo Superior de Investigaciones Científicas; Ministerio de Economía y Competitividad; Universidad de Málaga; Canadian Institute of Steel Construction; Universitat de Barcelona; Ministerio de Ciencia e Innovación","keywords":"Bystander effect; Glioblastoma; Medicine; Oncology; Cancer research; Immunology","score_opus":0.01404069675444263,"score_gpt":0.27276433393962607,"score_spread":0.25872363718518343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892207721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98352045,0.011972024,0.00025820817,0.0012958298,0.00015901952,0.001991844,0.000002689823,0.000051831805,0.0007481329],"genre_scores_gemma":[0.9812807,0.013891259,0.00060113455,0.0035527241,0.000083369996,0.00031525246,0.000009356575,0.0000783992,0.00018779204],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9982011,0.00012757565,0.00036045522,0.00051772146,0.00038121507,0.0004119384],"domain_scores_gemma":[0.99883145,0.000070270675,0.0001257336,0.00067792094,0.00012471559,0.00016988757],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016321849,0.00044606463,0.0004556384,0.00018409386,0.00019917969,0.00008009799,0.00015670933,0.00016678951,0.000094682604],"category_scores_gemma":[0.000005906812,0.00025355566,0.00015957048,0.00036954143,0.00016946979,0.000060290124,0.000039933773,0.00013588392,0.000036643363],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021134848,0.004319668,0.0020173036,0.000012248667,0.000688475,0.00042823525,0.013146209,0.00000570071,0.76207316,0.0008336505,0.00011155342,0.21425031],"study_design_scores_gemma":[0.020806236,0.0145272,0.0023212803,0.000047882353,0.000051010313,0.000020076692,0.0006066122,0.0003201504,0.9254834,0.00330051,0.032211512,0.00030410945],"about_ca_topic_score_codex":0.00023269896,"about_ca_topic_score_gemma":0.00014863451,"teacher_disagreement_score":0.2139462,"about_ca_system_score_codex":0.0003396058,"about_ca_system_score_gemma":0.0001395245,"threshold_uncertainty_score":0.99999166},"labels":[],"label_agreement":null},{"id":"W2945416434","doi":"10.1016/j.omto.2019.05.001","title":"An Oncolytic Adenovirus Vector Expressing p14 FAST Protein Induces Widespread Syncytium Formation and Reduces Tumor Growth Rate In Vivo","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; Cancer Research Society","keywords":"Oncolytic virus; In vivo; Cancer research; Oncolytic adenovirus; Virotherapy; Viral vector; Biology; Cancer; Cell; Cell growth; Cancer cell; Lung cancer; Medicine; Tumor cells; Pathology; Gene","score_opus":0.014921422829136525,"score_gpt":0.2870929348740132,"score_spread":0.2721715120448767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945416434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956528,0.0016147831,0.00036858756,0.00019108149,0.00011266966,0.0016116352,0.000024098834,0.000041007923,0.00038335208],"genre_scores_gemma":[0.9980534,0.00026069983,0.00046473034,0.00052993104,0.0001383055,0.00017992426,0.00004901545,0.0001091774,0.0002148523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997199,0.000523761,0.0004901549,0.0007321191,0.0004252354,0.0006297289],"domain_scores_gemma":[0.99865353,0.000036022582,0.00022695132,0.0006952246,0.00017631006,0.00021198949],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077481323,0.00041953666,0.00039112446,0.00023409791,0.000121613455,0.00021673153,0.0005044642,0.00026590517,0.00004999171],"category_scores_gemma":[0.000081834245,0.00041365685,0.000099092635,0.0003349053,0.00014589445,0.00006903732,0.00011416653,0.00032626925,0.000022458195],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020132123,0.00023639527,0.0002166259,0.00006003373,0.000055956036,0.00004126046,0.00034354624,0.00019765981,0.99139863,0.000033027074,0.000031425647,0.0053722155],"study_design_scores_gemma":[0.0025228544,0.004571707,0.00025375214,0.00014446425,0.0000100238185,0.000019749212,0.0002531618,0.0009866015,0.98984337,0.00015560076,0.00073720596,0.00050148304],"about_ca_topic_score_codex":0.00004633207,"about_ca_topic_score_gemma":0.00007048739,"teacher_disagreement_score":0.0048707323,"about_ca_system_score_codex":0.00014259986,"about_ca_system_score_gemma":0.000347768,"threshold_uncertainty_score":0.9998315},"labels":[],"label_agreement":null},{"id":"W2945607155","doi":"10.1016/j.omto.2019.05.004","title":"Assessing the Completeness of Reporting in Preclinical Oncolytic Virus Therapy Studies","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Ottawa Hospital; University of Ottawa","funders":"U.S. Food and Drug Administration; Government of Canada","keywords":"Medicine; Preclinical research; Oncolytic virus; Blinding; Inclusion and exclusion criteria; MEDLINE; Preclinical testing; Medical physics; Clinical study design; Clinical trial; Oncology; Pathology; Internal medicine; Alternative medicine; Cancer; Biology","score_opus":0.16571990755137075,"score_gpt":0.4718332725758467,"score_spread":0.30611336502447595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945607155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98253584,0.014898473,0.00017559822,0.00043088102,0.00024235925,0.0011623539,0.000005607847,0.00001909283,0.0005297682],"genre_scores_gemma":[0.99268705,0.005282612,0.00038129042,0.0011576895,0.00013065038,0.00008256839,0.000024116383,0.00008758298,0.00016645638],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99592716,0.0006711371,0.0015604184,0.0006604002,0.0006246341,0.0005562694],"domain_scores_gemma":[0.9969243,0.0002572801,0.0010740162,0.001299772,0.0003604023,0.00008425792],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032992498,0.00035440057,0.00070971483,0.00012082018,0.00010577551,0.000078214856,0.0007158807,0.00025131644,0.00003642815],"category_scores_gemma":[0.0005797167,0.00026198677,0.00033045156,0.00045611736,0.00032842284,0.00001546539,0.00021109666,0.00040637288,0.000015471163],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013260861,0.00034441744,0.011888731,0.00004266091,0.0003579536,0.000033718392,0.00029338663,0.0011976945,0.96592176,0.000030826206,0.000051497627,0.018511264],"study_design_scores_gemma":[0.0035194142,0.0041115764,0.005424444,0.00012701756,0.000015392734,0.000022279237,0.000712164,0.00058596133,0.9790975,0.00030361972,0.0056664147,0.000414218],"about_ca_topic_score_codex":0.000039054594,"about_ca_topic_score_gemma":0.00010586886,"teacher_disagreement_score":0.018097047,"about_ca_system_score_codex":0.000096672506,"about_ca_system_score_gemma":0.00049577345,"threshold_uncertainty_score":0.99998325},"labels":[],"label_agreement":null},{"id":"W2955578428","doi":"10.1016/j.omto.2019.06.004","title":"Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Terry Fox Foundation; Ontario Institute for Cancer Research; Francis Crick Institute","keywords":"Oncolytic virus; Vaccinia; Virus; Virology; Thymidine kinase; Biology; Apoptosis; Cancer; Viral replication; Cancer research; Programmed cell death; Cancer cell; Suicide gene; Genetic enhancement; Gene; Genetics; Herpes simplex virus","score_opus":0.014554761161068729,"score_gpt":0.3083931455120693,"score_spread":0.29383838435100057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955578428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881763,0.00934799,0.00042418845,0.00025695082,0.000084474515,0.0014746258,0.00011242031,0.000013340564,0.00010971488],"genre_scores_gemma":[0.9726981,0.025374584,0.00047335032,0.00074164313,0.00012221636,0.0002121443,0.00011177593,0.00008660868,0.0001795699],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99802214,0.0002108285,0.0004781845,0.00055770495,0.0003146297,0.00041652095],"domain_scores_gemma":[0.99882317,0.00007276301,0.00019110198,0.00057235494,0.00022521784,0.000115395036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005647223,0.0003056208,0.00046606862,0.00017703182,0.000060039336,0.000029551116,0.0002876462,0.00028754715,0.000077898614],"category_scores_gemma":[0.00004742692,0.00029325008,0.00019988103,0.00030584764,0.000081258215,0.000010261956,0.000078012,0.00014434873,0.0000040485643],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013852501,0.0003540259,0.003973813,0.00003803088,0.00022102754,0.0000013133078,0.00008613432,0.0004200058,0.9326551,0.000029629571,0.000065322696,0.048303094],"study_design_scores_gemma":[0.005999634,0.005565866,0.0012180147,0.00005037335,0.000017025948,0.0000018209035,0.000055750417,0.0004066576,0.9721388,0.00008788973,0.014123469,0.00033465188],"about_ca_topic_score_codex":0.00029172032,"about_ca_topic_score_gemma":0.00034832055,"teacher_disagreement_score":0.04796844,"about_ca_system_score_codex":0.00009860865,"about_ca_system_score_gemma":0.00029882172,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W2963978412","doi":"10.1016/j.omto.2019.07.003","title":"Coxsackievirus Type B3 Is a Potent Oncolytic Virus against KRAS-Mutant Lung Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Occupational Cancer Research Centre; St. Paul's Hospital; University of British Columbia","funders":"Natural Sciences and Engineering Research Council of Canada; Michael Smith Health Research BC; Terry Fox Research Institute; University of British Columbia; Canadian Lung Association; BC Cancer Foundation; Vancouver Coastal Health Research Institute; British Columbia Lung Association; Canadian Institutes of Health Research; Mitacs; International Association for the Study of Lung Cancer","keywords":"Oncolytic virus; KRAS; Virology; Adenocarcinoma; Coxsackievirus; Mutant; Cancer research; Virus; Biology; Mutation; Medicine; Enterovirus; Internal medicine; Cancer; Genetics; Gene","score_opus":0.01715183600050761,"score_gpt":0.29643740505648053,"score_spread":0.2792855690559729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2963978412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774651,0.01677121,0.0003616089,0.00045940737,0.0005329808,0.0015765355,0.00007165863,0.00007298166,0.0026885034],"genre_scores_gemma":[0.9835053,0.004948537,0.0003168547,0.00809045,0.00032339455,0.00007374319,0.0001805149,0.0002484709,0.0023127191],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958605,0.00031733816,0.0006285058,0.0011626057,0.00094572717,0.0010852843],"domain_scores_gemma":[0.99700093,0.00003198335,0.00023752333,0.0019054294,0.0004184023,0.00040572407],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005865202,0.0006712392,0.00060647767,0.0001987523,0.00017502769,0.00014722423,0.0010154148,0.00052739435,0.00040516237],"category_scores_gemma":[0.000058140027,0.00065897603,0.0004324607,0.0005824389,0.00017812362,0.000014789869,0.00029164445,0.0005055974,0.0008528697],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037881136,0.00037031516,0.0013545218,0.000045549998,0.0005281522,0.00015065084,0.0001691724,0.00036811855,0.9727174,0.000031321004,0.0015718924,0.018904787],"study_design_scores_gemma":[0.0036460166,0.0065203854,0.0004158271,0.00005305016,0.00004823608,0.00003913964,0.00007389177,0.0022093097,0.93684304,0.00006167654,0.049232133,0.00085731933],"about_ca_topic_score_codex":0.00004472977,"about_ca_topic_score_gemma":0.000036178455,"teacher_disagreement_score":0.04766024,"about_ca_system_score_codex":0.00029750646,"about_ca_system_score_gemma":0.0008307475,"threshold_uncertainty_score":0.9999251},"labels":[],"label_agreement":null},{"id":"W2970333537","doi":"10.1016/j.omto.2019.08.003","title":"Combination Therapy with Reovirus and ATM Inhibitor Enhances Cell Death and Virus Replication in Canine Melanoma","year":2019,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Yamaguchi University; University of Michigan","keywords":"Oncolytic virus; Cancer research; Combination therapy; Melanoma; Virotherapy; Cell culture; Cancer; Virology; Biology; Medicine; Virus; Pharmacology; Internal medicine","score_opus":0.012122621008826724,"score_gpt":0.2768667207527858,"score_spread":0.26474409974395907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970333537","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924059,0.0056522978,0.00020517653,0.00022247336,0.000038080354,0.00096434937,0.000010165548,0.00001701951,0.00048451882],"genre_scores_gemma":[0.9903339,0.007800658,0.00045736998,0.0006239607,0.00004802813,0.00008293507,0.00007299948,0.00006193594,0.0005182003],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983291,0.00016525507,0.00024366681,0.00067018706,0.0002802283,0.0003115398],"domain_scores_gemma":[0.99895793,0.00002510328,0.00012179247,0.0006792452,0.00011407008,0.0001018448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041484894,0.00026032352,0.00024117975,0.00010607014,0.000066527035,0.00006288819,0.00018107805,0.00018802655,0.000018637716],"category_scores_gemma":[0.000013584956,0.00022791246,0.00003809724,0.00019308989,0.00009354723,0.000013395299,0.000056367207,0.00016595262,0.0000073793262],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028472801,0.00021545448,0.008022415,0.000016435679,0.000048241538,0.000010628407,0.00014871817,0.000047663318,0.97588027,0.0000536743,0.000019664512,0.012689568],"study_design_scores_gemma":[0.004639103,0.008515366,0.004110215,0.000021150054,0.000005590767,0.00001298779,0.000044955217,0.0002957452,0.9779053,0.00011135843,0.004036743,0.00030148178],"about_ca_topic_score_codex":0.00010543394,"about_ca_topic_score_gemma":0.00023941767,"teacher_disagreement_score":0.012388087,"about_ca_system_score_codex":0.000053828808,"about_ca_system_score_gemma":0.00014607735,"threshold_uncertainty_score":0.9294},"labels":[],"label_agreement":null},{"id":"W3002247662","doi":"10.1016/j.omto.2020.01.002","title":"MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; Occupational Cancer Research Centre; St. Paul's Hospital; University of British Columbia","funders":"Providence Health Care Research Institute; Canadian Institutes of Health Research; BC Cancer Foundation; British Columbia Lung Association; Vancouver Coastal Health Research Institute; University of British Columbia; Michael Smith Health Research BC; Terry Fox Research Institute","keywords":"Oncolytic virus; KRAS; Adenocarcinoma; Cancer research; Coxsackievirus; Toxicity; Lung cancer; Cancer; Mutant; Cytotoxicity; Biology; Virus; In vitro; Medicine; Virology; Pathology; Gene; Internal medicine; Colorectal cancer","score_opus":0.050242848173631026,"score_gpt":0.33918163930300593,"score_spread":0.28893879112937493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002247662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750481,0.018993303,0.0025971336,0.001230556,0.000079629346,0.0009712047,0.00010057128,0.00004627844,0.0009332097],"genre_scores_gemma":[0.98674333,0.00811949,0.00049703364,0.0038183625,0.00026034762,0.000112162816,0.00016485716,0.00012415521,0.0001602554],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972427,0.00028738714,0.0005977315,0.0007269628,0.0005835963,0.0005616213],"domain_scores_gemma":[0.99810743,0.00003140695,0.0003273945,0.0007125533,0.00046541294,0.00035581776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036221286,0.0004050312,0.00046936754,0.000096703974,0.00013689273,0.000056984885,0.0007285595,0.00030322286,0.00009527027],"category_scores_gemma":[0.00017836412,0.0004211195,0.0002860175,0.00047607554,0.00014887455,0.000014287558,0.0001706793,0.000279595,0.000019008796],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002086988,0.0002244626,0.00040696556,0.00008464311,0.00031961032,0.000026344738,0.00023914581,0.003049834,0.96263134,0.000027129292,0.00042260427,0.03048095],"study_design_scores_gemma":[0.0019468525,0.0024093734,0.00012134456,0.00006936393,0.00005064434,0.00000428244,0.00007314892,0.007910766,0.9820131,0.000016435975,0.004939187,0.00044548122],"about_ca_topic_score_codex":0.00003630056,"about_ca_topic_score_gemma":0.000032476204,"teacher_disagreement_score":0.030035468,"about_ca_system_score_codex":0.00012752214,"about_ca_system_score_gemma":0.0007619353,"threshold_uncertainty_score":0.99982405},"labels":[],"label_agreement":null},{"id":"W3016228284","doi":"10.1016/j.omto.2020.03.018","title":"Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Ottawa Hospital; University of Ottawa","funders":"National Cancer Institute; National Institutes of Health; Ben and Catherine Ivy Foundation; Canary Foundation","keywords":"Chimeric antigen receptor; Oncolytic virus; Antigen; CD19; Cancer research; Cell therapy; Melanoma; Cell; Biology; Immunotherapy; Immunology; Virology; Immune system; Tumor cells","score_opus":0.01980434138450807,"score_gpt":0.3008079975698722,"score_spread":0.2810036561853641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016228284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860823,0.0039858744,0.0018205215,0.0015996651,0.00012947092,0.003014921,0.000025167892,0.000109054105,0.0032329853],"genre_scores_gemma":[0.98752135,0.0014007189,0.0015384736,0.00799724,0.00028144132,0.00013289828,0.000028594259,0.00016702192,0.0009322627],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969811,0.00026367823,0.00052266486,0.00061169284,0.00095243496,0.00066844374],"domain_scores_gemma":[0.9980392,0.00015861185,0.00015019909,0.00064727827,0.00041004622,0.0005946768],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00036100525,0.0004338715,0.0009174495,0.00020928573,0.000081476814,0.00003829995,0.0004041214,0.00019938135,0.0007392948],"category_scores_gemma":[0.000076739205,0.00038681977,0.00043010525,0.0006606625,0.000153401,0.000065358334,0.000111982605,0.00048422813,0.00010379675],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041493718,0.00048565128,0.0005502473,0.000104212835,0.00034772186,0.0004529893,0.0027217928,0.00038541705,0.9508326,0.000031953936,0.0008945983,0.039043415],"study_design_scores_gemma":[0.005622331,0.0070774774,0.0005843782,0.000066463064,0.000037906393,0.000014845976,0.0002531346,0.0007585036,0.94095886,0.000078272795,0.04419796,0.0003498769],"about_ca_topic_score_codex":0.00009629735,"about_ca_topic_score_gemma":0.0000026571404,"teacher_disagreement_score":0.043303367,"about_ca_system_score_codex":0.00023632444,"about_ca_system_score_gemma":0.000401255,"threshold_uncertainty_score":0.9998584},"labels":[],"label_agreement":null},{"id":"W3016877653","doi":"10.1016/j.omto.2020.04.001","title":"A Cross-Reactive Small Protein Binding Domain Provides a Model to Study Off-Tumor CAR-T Cell Toxicity","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Cancer Society","keywords":"CD28; Chimeric antigen receptor; T cell; Peripheral blood mononuclear cell; Toxicity; CD8; Cytokine release syndrome; Cytotoxic T cell; Adoptive cell transfer; Cancer research; Cytokine; T-cell receptor; Cell; Immunology; Medicine; Antigen; Pharmacology; Biology; Chemistry; Immune system; Internal medicine; In vitro; Biochemistry","score_opus":0.05817557353079079,"score_gpt":0.3426282375479575,"score_spread":0.28445266401716673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016877653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97796845,0.00024080147,0.007609008,0.0019031947,0.00003942782,0.010032872,0.00003705424,0.00020169943,0.0019674674],"genre_scores_gemma":[0.9823852,0.000015100386,0.009498784,0.004194668,0.00017887195,0.0007832469,0.000013968285,0.00021710867,0.002713016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9960355,0.00029170472,0.0006046731,0.0010198143,0.0011720653,0.0008762525],"domain_scores_gemma":[0.9976362,0.00008085075,0.00017544081,0.00087615,0.0003791032,0.0008522675],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000742039,0.00054667966,0.00082125154,0.0002269417,0.0002050522,0.0002049459,0.0005371628,0.00017186083,0.00030095573],"category_scores_gemma":[0.00019414129,0.0005022017,0.00033506614,0.00093461573,0.0001222303,0.00009499006,0.00025609322,0.0008009642,0.00010533246],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004717802,0.002042622,0.0015547947,0.00009854156,0.0003276173,0.0012466877,0.008657261,0.0007806892,0.96950847,0.000026357382,0.000038038346,0.011001111],"study_design_scores_gemma":[0.010084533,0.008518444,0.00024933935,0.000075652046,0.00007594236,0.0000264383,0.0016154464,0.010644409,0.96345854,0.00016803118,0.0044720853,0.0006111227],"about_ca_topic_score_codex":0.00008051017,"about_ca_topic_score_gemma":0.000021751252,"teacher_disagreement_score":0.010389988,"about_ca_system_score_codex":0.0006437951,"about_ca_system_score_gemma":0.0008031083,"threshold_uncertainty_score":0.999743},"labels":[],"label_agreement":null},{"id":"W3046293265","doi":"10.1016/j.omto.2020.07.008","title":"Molecular Rules Underpinning Enhanced Affinity Binding of Human T Cell Receptors Engineered for Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Biotechnology and Biological Sciences Research Council; University of Bristol; Engineering and Physical Sciences Research Council; University of Bath; Canolfan Ymchwil Canser Cymru; Cancer Research UK; Wellcome Trust","keywords":"Underpinning; Receptor; Immunotherapy; Cell biology; Chemistry; Cell; Computational biology; Biology; Biochemistry; Immunology; Immune system; Engineering","score_opus":0.04400329613346489,"score_gpt":0.32832955590108875,"score_spread":0.2843262597676239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046293265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9462325,0.0016475142,0.046529338,0.001106372,0.00013922184,0.0020427613,0.000030701893,0.00016000326,0.0021116128],"genre_scores_gemma":[0.9878025,0.00064787944,0.008887798,0.0013982356,0.00015836957,0.00012054576,0.00014296324,0.00024986395,0.0005918682],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997183,0.00014328661,0.000697623,0.0005768108,0.0007484647,0.00065078796],"domain_scores_gemma":[0.99824095,0.00017657394,0.00026219993,0.00066346885,0.0003362734,0.00032052322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00045141036,0.0004479377,0.0008657421,0.000247189,0.00013620702,0.000053573058,0.00043215667,0.0002891926,0.00064796326],"category_scores_gemma":[0.00011160452,0.0004551132,0.0005762808,0.00061262737,0.00015487599,0.00006542489,0.000064107044,0.00048749326,0.000022078138],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013064216,0.0003437524,0.000053436295,0.00023900894,0.0004448477,0.000039324328,0.001428702,0.00034388664,0.9823642,0.000362581,0.00013505384,0.01293882],"study_design_scores_gemma":[0.007895226,0.0031281975,0.000030812593,0.00010616769,0.00006332211,0.000004249366,0.00030185495,0.00094472687,0.9765014,0.00022030926,0.010399442,0.00040428722],"about_ca_topic_score_codex":0.000016254966,"about_ca_topic_score_gemma":7.5469694e-7,"teacher_disagreement_score":0.04157,"about_ca_system_score_codex":0.0002356053,"about_ca_system_score_gemma":0.00028935642,"threshold_uncertainty_score":0.9997901},"labels":[],"label_agreement":null},{"id":"W3090311836","doi":"10.1016/j.omto.2020.09.010","title":"Oncolytic reovirus-mediated recruitment of early innate immune responses reverses immunotherapy resistance in prostate tumors","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"Rosetrees Trust; Prostate Cancer UK; National Institute for Health and Care Research; Cancer Research UK","keywords":"Oncolytic virus; Innate immune system; Immunotherapy; Immune system; Cancer research; Immunology; Medicine; Prostate cancer; Biology; Internal medicine; Cancer","score_opus":0.04403722444281576,"score_gpt":0.3218439555676428,"score_spread":0.277806731124827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090311836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827529,0.012742301,0.00014869584,0.0014201752,0.00007474338,0.0021798315,0.00010272568,0.000045536082,0.00053309475],"genre_scores_gemma":[0.98860466,0.006607758,0.0010958714,0.0021408002,0.000076232165,0.00028974135,0.000108330496,0.00016628497,0.0009103266],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99599737,0.0007631194,0.0010109615,0.00081026217,0.00069552055,0.00072278635],"domain_scores_gemma":[0.9979412,0.000094356605,0.00041583937,0.0010228237,0.00029739353,0.00022838471],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00094631506,0.000495257,0.0006808421,0.00022313847,0.000091541246,0.000053817057,0.00080116483,0.0002442124,0.00004920653],"category_scores_gemma":[0.00027233394,0.0005022824,0.00027938717,0.00096326775,0.00031795158,0.000017633665,0.00015482541,0.0004250951,0.00003468078],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039848637,0.00030101123,0.001131335,0.000056834662,0.00023148034,0.00019435186,0.0010307258,0.00013623199,0.95341223,0.00005294,0.00014927454,0.003454922],"study_design_scores_gemma":[0.006007153,0.009272908,0.0020112616,0.00013446162,0.000012263411,0.0000049656005,0.00016094276,0.00006007285,0.95339996,0.00014933602,0.028210664,0.00057598465],"about_ca_topic_score_codex":0.00005810084,"about_ca_topic_score_gemma":0.0000986009,"teacher_disagreement_score":0.033841483,"about_ca_system_score_codex":0.00015945223,"about_ca_system_score_gemma":0.00081648893,"threshold_uncertainty_score":0.99974287},"labels":[],"label_agreement":null},{"id":"W3093325782","doi":"10.1016/j.omto.2020.10.007","title":"Oncolytic Rhabdovirus Vaccine Boosts Chimeric Anti-DEC205 Priming for Effective Cancer Immunotherapy","year":2020,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"Institute of Cancer Research; Canadian Institutes of Health Research; Mitacs; Terry Fox Research Institute; Canadian Cancer Society; McMaster University","keywords":"Oncolytic virus; Priming (agriculture); Immunotherapy; Virology; Biology; Cancer vaccine; Cancer immunotherapy; Medicine; Immunology; Immune system; Virus","score_opus":0.02298976060557455,"score_gpt":0.33258152679928465,"score_spread":0.3095917661937101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093325782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9620109,0.016514951,0.014176765,0.0029903597,0.00027497025,0.0036107665,0.00008246085,0.00014963702,0.00018916817],"genre_scores_gemma":[0.97810996,0.0059585082,0.0016223685,0.011590108,0.00088514737,0.0010576433,0.00013231576,0.00043852977,0.00020540594],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9967527,0.00027487395,0.0005323195,0.0010326527,0.00050700334,0.00090045057],"domain_scores_gemma":[0.9981526,0.000092412076,0.00025833305,0.00081937236,0.00031885778,0.0003584234],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044048822,0.00061734556,0.00066652015,0.00011593295,0.0002179912,0.000105203726,0.0007827004,0.00034879148,0.00007230632],"category_scores_gemma":[0.00012917684,0.0006052029,0.00047839546,0.0004892804,0.00011205345,0.000014484554,0.00014153926,0.00034376714,0.000026683065],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007685985,0.00022489161,0.0003446792,0.000054616088,0.0007204103,0.000022477449,0.00025821014,0.0011480597,0.8856973,0.000018129831,0.0010973735,0.10272786],"study_design_scores_gemma":[0.0068937517,0.009541845,0.00045138993,0.000034543875,0.000051288345,0.000008973945,0.000044402535,0.00160542,0.87407374,0.000060125898,0.10654292,0.0006916115],"about_ca_topic_score_codex":0.00003521737,"about_ca_topic_score_gemma":0.000035266297,"teacher_disagreement_score":0.10544555,"about_ca_system_score_codex":0.00016822675,"about_ca_system_score_gemma":0.00050844136,"threshold_uncertainty_score":0.9996399},"labels":[],"label_agreement":null},{"id":"W3123083777","doi":"10.1016/j.omto.2021.01.007","title":"A survivin-driven, tumor-activatable minicircle system for prostate cancer theranostics","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; London Health Sciences Centre; Robarts Clinical Trials; Western University","funders":"Natural Sciences and Engineering Research Council of Canada; Western University; Prostate Cancer Canada","keywords":"Minicircle; Survivin; Prostate cancer; Cancer research; Cytosine deaminase; Cancer; Biology; Reporter gene; Suicide gene; Medicine; Molecular biology; Genetic enhancement; Gene; Gene expression; Biochemistry; Genetics","score_opus":0.016905137106802977,"score_gpt":0.2800677928765921,"score_spread":0.26316265576978914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123083777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98045135,0.0058227326,0.011302367,0.00024621506,0.00058873446,0.00064086256,0.00023708258,0.000036282767,0.0006743651],"genre_scores_gemma":[0.9932347,0.0011918638,0.0015591232,0.0014196252,0.00027206825,0.0002583787,0.00020955493,0.00009035047,0.0017643202],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983496,0.00010464764,0.00032863134,0.0005544686,0.00020951935,0.00045312414],"domain_scores_gemma":[0.9985801,0.00003389742,0.00014719574,0.0006250222,0.0004987394,0.00011505706],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015369078,0.00028213617,0.00031529582,0.000036876965,0.0001259647,0.00008294087,0.00027443346,0.00016233082,0.000024874855],"category_scores_gemma":[0.000058300033,0.00028346354,0.00023348171,0.00015967272,0.00005969263,0.000005355384,0.0000855753,0.000109934386,0.000013525003],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034391144,0.00015365279,0.0007834154,0.00007913447,0.0003014003,0.000053812266,0.00010771223,0.0012416567,0.9907861,0.00008935075,0.0011641214,0.0048957686],"study_design_scores_gemma":[0.0015985811,0.0005431501,0.00013170017,0.000090130234,0.000043181848,0.000034795885,0.00035644707,0.0011020332,0.93125063,0.000043237313,0.064432815,0.00037330037],"about_ca_topic_score_codex":0.00004988802,"about_ca_topic_score_gemma":0.0000704213,"teacher_disagreement_score":0.06326869,"about_ca_system_score_codex":0.00007601649,"about_ca_system_score_gemma":0.00051662535,"threshold_uncertainty_score":0.99996173},"labels":[],"label_agreement":null},{"id":"W3125433041","doi":"10.1016/j.omto.2021.01.009","title":"Combining vanadyl sulfate with Newcastle disease virus potentiates rapid innate immune-mediated regression with curative potential in murine cancer models","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Ottawa Hospital; University of Ottawa; University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Ontario Veterinary College, University of Guelph; Cancer Research Society","keywords":"Oncolytic virus; Cancer research; Innate immune system; Tumor microenvironment; Immune system; Interferon; Immunology; Cancer; Newcastle disease; Monocyte; Immunotherapy; Biology; Virus; Medicine; Internal medicine","score_opus":0.019897762554918062,"score_gpt":0.29464746754851884,"score_spread":0.2747497049936008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125433041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785828,0.014753237,0.004824476,0.00086559897,0.00008649282,0.0006196077,0.00009664491,0.000033907752,0.00013725054],"genre_scores_gemma":[0.9900326,0.0073054163,0.00052942807,0.0007583465,0.00006674543,0.0001548737,0.0005902855,0.0001463899,0.00041591175],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99705213,0.0003979151,0.00040445355,0.00081357965,0.00062933506,0.0007026107],"domain_scores_gemma":[0.99820465,0.000021429933,0.0002037407,0.0008056802,0.00045939744,0.00030511923],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00025234703,0.0004851069,0.00043839912,0.00015482005,0.00016614115,0.00010128621,0.0003726217,0.00018774478,0.00009991796],"category_scores_gemma":[0.000028589524,0.0003844919,0.00013747394,0.00060821313,0.00020951698,0.000028898126,0.00016770331,0.00039009028,0.00000477819],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014762129,0.00051443285,0.0005369766,0.000027822316,0.00042732587,0.0015550987,0.00020918749,0.037155665,0.94067997,0.000017801993,0.000055017903,0.0040586046],"study_design_scores_gemma":[0.008097046,0.0029156154,0.0005542889,0.00022219363,0.000050831823,0.000026067202,0.00016819472,0.012184676,0.9740451,0.00017123591,0.000904311,0.0006604599],"about_ca_topic_score_codex":0.00021077115,"about_ca_topic_score_gemma":0.0009060305,"teacher_disagreement_score":0.03336514,"about_ca_system_score_codex":0.00010886993,"about_ca_system_score_gemma":0.0010542055,"threshold_uncertainty_score":0.9998607},"labels":[],"label_agreement":null},{"id":"W3129515331","doi":"10.1016/j.omto.2021.02.009","title":"Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Winship Cancer Institute; National Cancer Institute; National Institutes of Health; Genentech; AstraZeneca; Oncolytics Biotech; Minneapolis Medical Research Foundation; Bristol-Myers Squibb; GlaxoSmithKline; Multiple Myeloma Research Foundation; American Cancer Society","keywords":"Oncolytic virus; Herpes simplex virus; Tropism; Virus; Biology; Virology; Viral replication; Cell culture; Cancer cell; Cancer research; Cancer","score_opus":0.014863387662776239,"score_gpt":0.2949697748991098,"score_spread":0.2801063872363336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129515331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934683,0.004622838,0.00019930044,0.0002738509,0.00009630814,0.00053015625,0.00003702699,0.000019375535,0.00075284555],"genre_scores_gemma":[0.9928354,0.0037126013,0.00060668687,0.0020449723,0.00010193149,0.000077793666,0.000051209776,0.00009845197,0.00047092972],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997323,0.00041005271,0.00044294298,0.0007516708,0.00037216817,0.00070019043],"domain_scores_gemma":[0.99879986,0.00006246155,0.00009018038,0.0007294104,0.00012242967,0.00019568497],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00047186553,0.00037449133,0.00042851278,0.00019984855,0.00006475753,0.00008976589,0.0003035957,0.000347239,0.00007722938],"category_scores_gemma":[0.0000818534,0.00040924668,0.00013591984,0.0005675967,0.00014843167,0.000010175184,0.00020688784,0.00027945565,0.000015322585],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002107074,0.00042807186,0.00019906608,0.000026806669,0.00007031097,0.00053835,0.00012047732,0.00043229264,0.9497321,0.000010231771,0.00011753566,0.04621765],"study_design_scores_gemma":[0.003451336,0.00101976,0.00031835507,0.000028706923,0.000007556527,0.000024248258,0.000073975934,0.00046394844,0.95498294,0.0001768915,0.0390252,0.0004270606],"about_ca_topic_score_codex":0.000062515915,"about_ca_topic_score_gemma":0.0012669646,"teacher_disagreement_score":0.045790587,"about_ca_system_score_codex":0.00013797231,"about_ca_system_score_gemma":0.0005500871,"threshold_uncertainty_score":0.99983597},"labels":[],"label_agreement":null},{"id":"W3155151917","doi":"10.1016/j.omto.2021.04.002","title":"Angiogenesis-related non-coding RNAs and gastrointestinal cancer","year":2021,"lang":"en","type":"review","venue":"Molecular Therapy — Oncolytics","topic":"Cancer-related molecular mechanisms research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Merck KGaA","keywords":"Angiogenesis; Gastrointestinal cancer; Coding (social sciences); Computational biology; Cancer research; Cancer; Biology; Medicine; Colorectal cancer; Genetics; Mathematics","score_opus":0.03504720043554781,"score_gpt":0.36022704629734364,"score_spread":0.3251798458617958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3155151917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011765526,0.9694861,0.02822783,0.000055008186,0.00029797442,0.0012786573,0.0000969664,0.000037942587,0.00040185463],"genre_scores_gemma":[0.0001451949,0.9950997,0.0016224945,0.00023415087,0.00030985707,0.0003590976,0.000610626,0.00035482625,0.0012640228],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99592465,0.0003992065,0.00081739726,0.0013726716,0.0005803697,0.0009057217],"domain_scores_gemma":[0.997729,0.000044036606,0.00042188447,0.0011099947,0.00031607173,0.00037903275],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00042323984,0.00095007673,0.0015852541,0.00027618816,0.0001855044,0.00017796233,0.0006349481,0.00084492285,0.00011953604],"category_scores_gemma":[0.00011844193,0.0009387117,0.0009965095,0.0006616713,0.00018754056,0.00000605881,0.00050537725,0.00075165625,0.00002463424],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050549683,0.00015877598,0.0000016493791,0.0018733211,0.0015039021,0.00076200266,0.000027535849,0.00009168062,0.102800235,0.00012052547,0.00088171335,0.8917281],"study_design_scores_gemma":[0.0011300083,0.00055683794,0.0000010095456,0.0066058584,0.0005718388,0.0012154484,0.000020184983,0.00011432758,0.035267245,0.000019065094,0.95343995,0.0010581997],"about_ca_topic_score_codex":0.0000466081,"about_ca_topic_score_gemma":0.000017142127,"teacher_disagreement_score":0.9525583,"about_ca_system_score_codex":0.000247526,"about_ca_system_score_gemma":0.0016638507,"threshold_uncertainty_score":0.9993063},"labels":[],"label_agreement":null},{"id":"W3158023608","doi":"10.1016/j.omto.2021.04.015","title":"MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Medizinischen Fakultät Heidelberg, Universität Heidelberg; Helmholtz Association; Deutsche Krebshilfe; Universität Heidelberg; Deutsches Krebsforschungszentrum","keywords":"Oncolytic virus; Pancreatic cancer; Cancer research; Virotherapy; Measles virus; Cytosine deaminase; Medicine; Prodrug; Cancer; Genetic enhancement; Virology; Pharmacology; Biology; Internal medicine; Vaccination; Measles","score_opus":0.026345778887391702,"score_gpt":0.32879804360283643,"score_spread":0.30245226471544473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3158023608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765403,0.013762397,0.0071875933,0.000582914,0.00016386737,0.0011058634,0.00023214551,0.000025006402,0.00039991594],"genre_scores_gemma":[0.97583383,0.013042306,0.00448574,0.0034163557,0.00039803,0.00044763795,0.00025948603,0.00023571656,0.0018808764],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975081,0.00024422084,0.0004971165,0.00070416514,0.00044782655,0.000598544],"domain_scores_gemma":[0.9978349,0.00008144264,0.00022930786,0.00090723654,0.00076894445,0.00017816451],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004108388,0.00040516097,0.0005715179,0.00009700418,0.000119712175,0.000045524608,0.00038815362,0.00031107818,0.000095532174],"category_scores_gemma":[0.00011915726,0.0004119974,0.00044957636,0.0003400333,0.00023394883,0.000006723736,0.00008690377,0.00017582055,0.000008756132],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040848646,0.00040447697,0.00011854199,0.000063890715,0.0008119278,0.000037218935,0.0001580198,0.00032829941,0.97311515,0.00007064066,0.00046122263,0.020345762],"study_design_scores_gemma":[0.0037746744,0.0032570434,0.000088459004,0.00006039509,0.0000671676,0.000021203254,0.000112858805,0.00024482503,0.9671521,0.00022144263,0.024561884,0.00043792173],"about_ca_topic_score_codex":0.000052419007,"about_ca_topic_score_gemma":0.0002474929,"teacher_disagreement_score":0.024100661,"about_ca_system_score_codex":0.00012705762,"about_ca_system_score_gemma":0.0010685286,"threshold_uncertainty_score":0.99983317},"labels":[],"label_agreement":null},{"id":"W3163408869","doi":"10.1016/j.omto.2021.05.007","title":"Deletion of immunomodulatory genes as a novel approach to oncolytic vaccinia virus development","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Children's Hospital of Eastern Ontario; University Health Network","funders":"Canadian Cancer Society Research Institute","keywords":"Oncolytic virus; Vaccinia; Biology; Virus; Virotherapy; Immune system; Cancer research; Interferon; Gene; Virology; Mutant; Immunology; Genetics","score_opus":0.025663920561004316,"score_gpt":0.3008025625386601,"score_spread":0.2751386419776558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163408869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751598,0.005589279,0.016502699,0.00012113415,0.00011242254,0.00067932304,0.000018388086,0.000025508636,0.001791439],"genre_scores_gemma":[0.97913,0.00082049414,0.016650418,0.0019550647,0.00013363385,0.000165161,0.00022329576,0.0001318517,0.0007900739],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973657,0.00017412023,0.0005667567,0.000736253,0.00062095205,0.0005361784],"domain_scores_gemma":[0.9980372,0.00001918724,0.00015564349,0.0010577664,0.00052313216,0.00020707678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00050835137,0.000371506,0.00040758922,0.00015008535,0.00012380794,0.000050207665,0.00053083163,0.00028523643,0.00004987817],"category_scores_gemma":[0.00007819739,0.0003950527,0.0002248786,0.0004833333,0.000069536654,0.000006510214,0.00024946604,0.00018885381,0.000055169574],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018449556,0.00097402855,0.0000641309,0.00003481537,0.00038011352,0.000020351546,0.00022624744,0.0015634792,0.96920043,0.00009602608,0.00013129642,0.025464108],"study_design_scores_gemma":[0.0019203766,0.0022510209,0.00031906227,0.000024627208,0.000018441995,0.000044872497,0.00009167914,0.00018998308,0.9478596,0.000037629827,0.046813726,0.00042898805],"about_ca_topic_score_codex":0.00002036221,"about_ca_topic_score_gemma":0.000036472702,"teacher_disagreement_score":0.046682432,"about_ca_system_score_codex":0.00015807457,"about_ca_system_score_gemma":0.0015058599,"threshold_uncertainty_score":0.99985015},"labels":[],"label_agreement":null},{"id":"W4200118074","doi":"10.1016/j.omto.2021.12.016","title":"Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade","year":2021,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute; Kanae Foundation for the Promotion of Medical Science; National Institutes of Health; Neuroendocrine Tumor Research Foundation; Ottawa Hospital Research Institute","keywords":"Oncolytic virus; Neuroendocrine tumors; Vaccinia; Cancer research; Virus; Apoptosis; CD8; Biology; Immune system; Immunology; Medicine; Internal medicine","score_opus":0.013508484088663994,"score_gpt":0.28379881088495107,"score_spread":0.27029032679628706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200118074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900786,0.006753966,0.00057610864,0.0012704871,0.00011079869,0.00086483586,0.0000777899,0.00006749525,0.0001998711],"genre_scores_gemma":[0.99213284,0.002515385,0.0017296962,0.0022865394,0.0002071273,0.00009885083,0.00021027193,0.00017754808,0.00064175634],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99636066,0.00057213334,0.00067415263,0.0009944787,0.0005304499,0.00086812896],"domain_scores_gemma":[0.99770993,0.00007641604,0.00015898331,0.0012245381,0.00037572405,0.00045439907],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038983714,0.00056909665,0.00069553277,0.00018780987,0.00019948838,0.00016274782,0.00038874132,0.00013137386,0.00010257785],"category_scores_gemma":[0.00035886065,0.0005815959,0.00026067125,0.0006439373,0.00013305523,0.000009300105,0.00037555135,0.00036055018,0.000043003434],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028099408,0.0003857459,0.0000759362,0.00003839924,0.0004679935,0.0014623554,0.00014267389,0.00034567213,0.9840298,0.000015039276,0.00009077003,0.010135615],"study_design_scores_gemma":[0.0027013342,0.0066564227,0.0005600372,0.000049890208,0.00008491428,0.0006930785,0.00014849716,0.00020989538,0.98016423,0.000086163,0.008043124,0.0006024294],"about_ca_topic_score_codex":0.000090347065,"about_ca_topic_score_gemma":0.00021308358,"teacher_disagreement_score":0.0095331855,"about_ca_system_score_codex":0.00009647095,"about_ca_system_score_gemma":0.0006210989,"threshold_uncertainty_score":0.99966353},"labels":[],"label_agreement":null},{"id":"W4210729268","doi":"10.1016/j.omto.2022.01.009","title":"Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Ottawa Hospital; Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"","keywords":"Bladder cancer; Oncolytic virus; Immunotherapy; Vesicular stomatitis virus; Cystectomy; Medicine; Cancer research; Cancer; Oncolytic adenovirus; Oncology; Immunology; Virus; Internal medicine","score_opus":0.016642566042290707,"score_gpt":0.30906429545067116,"score_spread":0.29242172940838046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210729268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000365,0.005897203,0.0009103286,0.0009278151,0.00020050093,0.0015618309,0.000088349756,0.000059318223,0.00035099513],"genre_scores_gemma":[0.98941034,0.0018965453,0.000697426,0.0052595185,0.00018914978,0.0013627021,0.00013126536,0.00024997446,0.00080307515],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99567235,0.0006011982,0.000690506,0.0009664057,0.0010605128,0.001009007],"domain_scores_gemma":[0.9981172,0.00004681615,0.00024419738,0.0011973,0.00016165772,0.00023279317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00076865574,0.0005966851,0.0006247357,0.00028721863,0.0003048215,0.00011250039,0.0009580129,0.00023416406,0.00046158454],"category_scores_gemma":[0.000035642923,0.00056236587,0.0002730149,0.0007547231,0.00027422572,0.000016969056,0.00026387468,0.000768726,0.000017622224],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060926904,0.00082181994,0.0013704832,0.00002058417,0.0005644535,0.0003265376,0.00035740767,0.003384457,0.95520914,0.000046292855,0.00028164836,0.03152451],"study_design_scores_gemma":[0.012089022,0.017216029,0.00348936,0.000033696597,0.000054067317,0.00011498866,0.00038985413,0.0016078149,0.9127033,0.00023357123,0.05061391,0.0014543874],"about_ca_topic_score_codex":0.00030798334,"about_ca_topic_score_gemma":0.0006761544,"teacher_disagreement_score":0.050332263,"about_ca_system_score_codex":0.00050379813,"about_ca_system_score_gemma":0.00091498205,"threshold_uncertainty_score":0.9996828},"labels":[],"label_agreement":null},{"id":"W4212894372","doi":"10.1016/j.omto.2022.02.017","title":"NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Biochemical and Molecular Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Beatrice Hunter Cancer Research Institute; University of New Brunswick; University of Prince Edward Island; Nova Scotia Health Authority; Dalhousie University","funders":"National Institute of General Medical Sciences","keywords":"Multiple myeloma; NAD+ kinase; Virology; Cancer research; Chemistry; Biology; Immunology; Biochemistry; Enzyme","score_opus":0.025562086740894593,"score_gpt":0.2910022954302799,"score_spread":0.2654402086893853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212894372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438065,0.001826492,0.0013246774,0.0005262772,0.00015837722,0.00062952825,0.000026257952,0.00003084681,0.0010969139],"genre_scores_gemma":[0.9960002,0.00038746747,0.00068514806,0.0016272403,0.00011568477,0.0003849492,0.00023984199,0.00007420569,0.0004852663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9972596,0.0003794973,0.00039730428,0.0007194287,0.0006546529,0.0005895291],"domain_scores_gemma":[0.9989134,0.00002959105,0.00012124901,0.0006763548,0.000095339645,0.00016405575],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052795693,0.00029730127,0.00029308622,0.00016671428,0.00025152837,0.000046600035,0.00060561224,0.00020843951,0.00013019194],"category_scores_gemma":[0.00013166474,0.0003168604,0.0002449657,0.0005705813,0.00009148149,0.0000059852505,0.0004294402,0.00046159234,0.000020535055],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005393725,0.0004072271,0.0007528768,0.000010734876,0.000079419515,0.0001046062,0.000076709985,0.00020208042,0.9809481,0.00005522215,0.00041376604,0.016409865],"study_design_scores_gemma":[0.0019319645,0.0009630903,0.0004821176,0.000008074072,0.000009646879,0.00002578936,0.00013620793,0.0003438157,0.90194124,0.00012347769,0.093649134,0.00038543012],"about_ca_topic_score_codex":0.00012970003,"about_ca_topic_score_gemma":0.00011072368,"teacher_disagreement_score":0.093235366,"about_ca_system_score_codex":0.00017711158,"about_ca_system_score_gemma":0.0002610076,"threshold_uncertainty_score":0.99992836},"labels":[],"label_agreement":null},{"id":"W4220684155","doi":"10.1016/j.omto.2022.03.006","title":"IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activity","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Virotherapy; Blockade; Immunotherapy; Cancer research; Monoclonal antibody; Interferon; Virology; Immunity; Immunology; Immune system; Virus; Biology; Antibody; Receptor","score_opus":0.010529561693263072,"score_gpt":0.26953644687245354,"score_spread":0.25900688517919046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220684155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431163,0.0021865997,0.00072623574,0.0005042839,0.00008819787,0.0017858146,0.00010816732,0.00005589243,0.00023318654],"genre_scores_gemma":[0.99502045,0.0009118406,0.0010508106,0.0009960502,0.000111068206,0.0005076115,0.00010013916,0.00015672612,0.0011452753],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966446,0.0005169467,0.00030902677,0.00095946563,0.00085626694,0.0007136679],"domain_scores_gemma":[0.9982847,0.000047070094,0.00017804462,0.0009735888,0.00012512106,0.00039149096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005758817,0.00047558782,0.00041827065,0.00018101133,0.00042582734,0.00008275524,0.0005874952,0.00015850336,0.00010095],"category_scores_gemma":[0.000048503418,0.0004362858,0.000137132,0.0004789327,0.00014133072,0.000011658956,0.00053118507,0.00043786925,0.000016396903],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007563178,0.0011605225,0.0000724802,0.000047242836,0.00011840979,0.00015516102,0.0002275064,0.0016406638,0.98439115,0.0000014250749,0.00041471873,0.0042075585],"study_design_scores_gemma":[0.0026188006,0.014799396,0.000113306676,0.00003588713,0.000027866972,0.000040984207,0.00008252806,0.0002779834,0.9593867,0.000019587851,0.022024773,0.0005721731],"about_ca_topic_score_codex":0.000029358423,"about_ca_topic_score_gemma":0.00004951802,"teacher_disagreement_score":0.02500442,"about_ca_system_score_codex":0.00015877749,"about_ca_system_score_gemma":0.0005252581,"threshold_uncertainty_score":0.9998089},"labels":[],"label_agreement":null},{"id":"W4280561406","doi":"10.1016/j.omto.2022.04.004","title":"Dependency of EGFR activation in vanadium-based sensitization to oncolytic virotherapy","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"RNA regulation and disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research; Ministère de l’Éducation, Gouvernement de l’Ontario; University of Ottawa; Terry Fox Research Institute; Canadian Cancer Society; Lotte and John Hecht Memorial Foundation; Colorado State University","keywords":"Oncolytic virus; Vanadate; Cancer research; Virotherapy; Sodium orthovanadate; Epidermal growth factor receptor; Kinase; Biology; Cell biology; Receptor; Biochemistry","score_opus":0.00979807380116661,"score_gpt":0.26120024497144595,"score_spread":0.25140217117027935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280561406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.969806,0.00013465795,0.027775545,0.000929879,0.00007802337,0.0006537872,0.000017668292,0.000011789363,0.000592639],"genre_scores_gemma":[0.9949804,0.000019184585,0.00096635945,0.0034230333,0.000039556966,0.000089177665,0.00016326288,0.000041765623,0.00027723657],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99866825,0.00019020881,0.0002991819,0.0003077726,0.00033405918,0.00020053741],"domain_scores_gemma":[0.99927396,0.000018539959,0.00012684113,0.00038497173,0.00008709616,0.00010859203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020953022,0.00015755856,0.00016759161,0.00019667935,0.00007891162,0.00001450407,0.00018150198,0.00008003992,0.00013175105],"category_scores_gemma":[0.000047936068,0.000183418,0.00010290088,0.0004235147,0.00002717774,0.000004952332,0.000045394216,0.000086433545,0.0000037902423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006217622,0.00032720627,0.002352695,0.000009278189,0.000024373758,0.000008039943,0.0000837023,0.071837045,0.9187059,0.00028497484,0.00014751586,0.005597519],"study_design_scores_gemma":[0.0047622076,0.0014541249,0.008891117,0.000020638507,0.000013699687,0.000004513315,0.00012998207,0.0074719572,0.95806617,0.0005509324,0.018175,0.0004596726],"about_ca_topic_score_codex":0.000054097134,"about_ca_topic_score_gemma":0.000039115443,"teacher_disagreement_score":0.06436508,"about_ca_system_score_codex":0.00015464552,"about_ca_system_score_gemma":0.00032607824,"threshold_uncertainty_score":0.7479569},"labels":[],"label_agreement":null},{"id":"W4303575247","doi":"10.1016/j.omto.2022.10.003","title":"Enhanced genomic stability of new miRNA-regulated oncolytic coxsackievirus B3","year":2022,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada); St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Mitacs; Michael Smith Health Research BC; Canadian Cancer Society; University of British Columbia; Canadian Lung Association; British Columbia Lung Association","keywords":"Oncolytic virus; microRNA; Biology; Coding region; Genome; Virology; Reversion; Untranslated region; CRISPR; Virus; Coxsackievirus; Cancer research; Viral replication; Gene; Molecular biology; Computational biology; Genetics; Enterovirus; RNA; Phenotype","score_opus":0.027884358933590852,"score_gpt":0.30558367684842763,"score_spread":0.27769931791483676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303575247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911922,0.0044789664,0.0013424074,0.00040949922,0.00020162546,0.0011253183,0.000075363845,0.00003467572,0.001139928],"genre_scores_gemma":[0.9960662,0.0006239408,0.0004644598,0.0008566508,0.00013571743,0.00011557943,0.00016975783,0.00013338224,0.0014342915],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654347,0.00054957246,0.0006635972,0.0007897454,0.00078502664,0.0006686181],"domain_scores_gemma":[0.9976872,0.000039893413,0.00030721445,0.0014752791,0.00020537477,0.0002850202],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0007903805,0.0004135124,0.0005147031,0.00014432825,0.000228584,0.00003449728,0.0009988406,0.00019844205,0.0010407491],"category_scores_gemma":[0.000075536795,0.0004536606,0.00038021657,0.0005347864,0.0002176867,0.0000065772774,0.00043963254,0.00039786636,0.00002873502],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056604836,0.0004762106,0.00014016105,0.00002188981,0.00031425845,0.000016008222,0.0002427133,0.0020047945,0.96599454,0.000035337987,0.0004305867,0.024663033],"study_design_scores_gemma":[0.0036817326,0.007583559,0.0003517317,0.000008393421,0.000030078727,0.000014072706,0.00010229332,0.00032794045,0.97170025,0.0003032469,0.015435107,0.0004615665],"about_ca_topic_score_codex":0.00010362639,"about_ca_topic_score_gemma":0.00009529415,"teacher_disagreement_score":0.024201466,"about_ca_system_score_codex":0.00031174973,"about_ca_system_score_gemma":0.0013149158,"threshold_uncertainty_score":0.99987245},"labels":[],"label_agreement":null},{"id":"W4319915108","doi":"10.1016/j.omto.2023.02.003","title":"Targeting carcinoembryonic antigen-expressing tumors using a novel transcriptional and translational dual-regulated oncolytic herpes simplex virus type 1","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Biotech (Canada)","funders":"College of Medicine, University of Florida","keywords":"Oncolytic virus; Herpes simplex virus; Immune system; Virus; Cancer research; Biology; Viral replication; Carcinoembryonic antigen; Immunotherapy; Virology; Immunology; Cancer","score_opus":0.04717215919280651,"score_gpt":0.3268019723086337,"score_spread":0.27962981311582724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319915108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99059796,0.0039262325,0.00421821,0.00028591987,0.0001396106,0.0005958952,0.000087100736,0.000087952976,0.00006111945],"genre_scores_gemma":[0.99543935,0.0009291677,0.0020852552,0.0004643341,0.00025932296,0.000023953908,0.00047592912,0.00015031906,0.00017237692],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99721587,0.00019426472,0.00049714954,0.00072236813,0.00063036394,0.0007399804],"domain_scores_gemma":[0.99893844,0.000046308924,0.00013372494,0.00041737393,0.00024743873,0.00021671288],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062035397,0.00041746374,0.00036182505,0.0002325939,0.0003671934,0.0001221718,0.0002630353,0.0002943627,0.000077256074],"category_scores_gemma":[0.000050595787,0.00044179446,0.00018260663,0.000715923,0.00024277055,0.000020025383,0.00007688651,0.00023048939,0.000014795093],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013864241,0.0001619027,0.00026396572,0.00002894161,0.00022587697,0.000042845695,0.00024280627,0.017526582,0.9745961,0.00006079174,0.00008069466,0.0053831036],"study_design_scores_gemma":[0.0045984336,0.0016329709,0.0034092888,0.00008315347,0.000047327398,0.00007343211,0.00017174534,0.06432566,0.9078786,0.0003888691,0.016478885,0.00091167766],"about_ca_topic_score_codex":0.000044832046,"about_ca_topic_score_gemma":0.000031967487,"teacher_disagreement_score":0.066717505,"about_ca_system_score_codex":0.00005988049,"about_ca_system_score_gemma":0.0006246421,"threshold_uncertainty_score":0.99980336},"labels":[],"label_agreement":null},{"id":"W4321378595","doi":"10.1016/j.omto.2023.02.006","title":"Targeting receptor tyrosine kinases in ovarian cancer: Genomic dysregulation, clinical evaluation of inhibitors, and potential for combinatorial therapies","year":2023,"lang":"en","type":"review","venue":"Molecular Therapy — Oncolytics","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; University of Science and Technology of China; American Cancer Society","keywords":"Receptor tyrosine kinase; Cancer research; Medicine; Ovarian cancer; Targeted therapy; Cancer; Metastasis; Context (archaeology); Cabozantinib; Biology; Bioinformatics; Internal medicine; Receptor","score_opus":0.0893979594266115,"score_gpt":0.41769948961889636,"score_spread":0.32830153019228486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321378595","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008699361,0.983776,0.000083923216,0.00034322633,0.0017698042,0.0051114587,0.00018070008,0.000028171851,0.0000073708998],"genre_scores_gemma":[0.0046384665,0.9915804,0.00078447186,0.00005799398,0.0010698322,0.0010654784,0.0006423938,0.00014017076,0.000020791773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967863,0.0004529915,0.0013711636,0.0005704091,0.0005461171,0.00027300234],"domain_scores_gemma":[0.99810654,0.00029603828,0.00074638985,0.00034724755,0.00040389106,0.000099908524],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018420235,0.00041053744,0.0018523637,0.00020533685,0.000064913576,0.000037620244,0.000108856635,0.00044846747,0.000041737854],"category_scores_gemma":[0.00018525247,0.00034566954,0.00047920406,0.00036307878,0.00010357652,0.000036794896,0.000043256154,0.0002355851,0.0000029398227],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033312515,0.0007369033,0.0004122607,0.0033966813,0.0016244868,0.00001598092,0.00012224134,0.00008115721,0.00023019375,0.00033939574,0.0006465151,0.9920611],"study_design_scores_gemma":[0.044453662,0.003914179,0.0021767225,0.029341744,0.0113844825,0.000016700375,0.00010790746,0.0020507788,0.0007237604,0.002192496,0.9022806,0.0013569175],"about_ca_topic_score_codex":0.000084392814,"about_ca_topic_score_gemma":0.000009463141,"teacher_disagreement_score":0.9907041,"about_ca_system_score_codex":0.0006296787,"about_ca_system_score_gemma":0.0014078565,"threshold_uncertainty_score":0.9998995},"labels":[],"label_agreement":null},{"id":"W4363676920","doi":"10.1016/j.omto.2023.04.001","title":"Vaccinia virus and peptide-receptor radiotherapy synergize to improve treatment of peritoneal carcinomatosis","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; Princess Margaret Cancer Centre; University of Toronto; Canada Research Chairs; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation","keywords":"Somatostatin receptor; Oncolytic virus; Cancer research; Biodistribution; Vaccinia; Medicine; Somatostatin receptor 2; Receptor; Chemistry; Internal medicine; Biology; In vivo","score_opus":0.020962838391486664,"score_gpt":0.3293578608040862,"score_spread":0.30839502241259953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4363676920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934021,0.0021536464,0.000067326255,0.002363999,0.0001372994,0.0014905527,0.000057054982,0.00013692673,0.0001910455],"genre_scores_gemma":[0.98563415,0.008115931,0.0030056373,0.00062669563,0.00015156038,0.000261863,0.000024537127,0.000132543,0.002047079],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980243,0.00008801832,0.00036548733,0.00048168088,0.0005044539,0.0005360806],"domain_scores_gemma":[0.9986876,0.000119720105,0.00008568351,0.0005779163,0.00012331922,0.00040572733],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000095782256,0.00031428726,0.0006329032,0.00030454932,0.00006833397,0.000031825082,0.00014482935,0.000028780125,0.00008954913],"category_scores_gemma":[0.000056978577,0.00026126447,0.00018488371,0.0005910597,0.00009039997,0.000051196166,0.000048614955,0.000112452966,0.00005942335],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013495977,0.00038420488,0.0033109826,0.00006896492,0.00024289708,0.0011225637,0.00051302265,0.000032575408,0.96637595,0.000043648924,0.00055478915,0.026000783],"study_design_scores_gemma":[0.005556734,0.011074905,0.0044773915,0.00004404649,0.000045117507,0.00015743585,0.00017176472,0.0005052617,0.9245826,0.00003102173,0.053095713,0.00025802632],"about_ca_topic_score_codex":0.00013256105,"about_ca_topic_score_gemma":0.000012330918,"teacher_disagreement_score":0.052540924,"about_ca_system_score_codex":0.00022068733,"about_ca_system_score_gemma":0.00016154764,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W4388153112","doi":"10.1016/j.omto.2023.100743","title":"Improved oncolytic activity of a reovirus mutant that displays enhanced virus spread due to reduced cell attachment","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Li Ka Shing Institute of Virology, University of Alberta; National Institutes of Health; Canada Research Chairs; Canadian Cancer Society Research Institute; Canadian Institutes of Health Research; Cancer Research Society; Cure Brain Cancer Foundation; Emory University; University of Alberta; Faculty of Medicine and Dentistry, University of Alberta; Cancer Research Institute","keywords":"Oncolytic virus; Virus; Mutant; Cancer cell; Biology; Infectivity; Potency; Virology; Cancer; Cell culture; Cancer research; Myxoma virus; In vitro; Gene; Biochemistry; Genetics","score_opus":0.025957205564137865,"score_gpt":0.3273071999934433,"score_spread":0.30134999442930543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388153112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102026,0.0004597958,0.0051683425,0.00041582785,0.00025744992,0.0018049376,0.00013803216,0.000086232605,0.00064910523],"genre_scores_gemma":[0.9959523,0.00095315394,0.0004776425,0.0006696091,0.00014697404,0.00031255122,0.000105320236,0.00017047345,0.001211993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963887,0.00033752434,0.0005040197,0.0010170889,0.00076704734,0.0009856495],"domain_scores_gemma":[0.9974075,0.00007062004,0.0002763416,0.0016107237,0.0002276338,0.0004072086],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00077820284,0.0005532086,0.0006442817,0.00027860134,0.00015296854,0.000063151165,0.00084461336,0.00037160335,0.00005587247],"category_scores_gemma":[0.000090521164,0.00054811843,0.00038605713,0.000870057,0.0001363345,0.000011695694,0.00036838217,0.0003219325,0.00011137022],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00630446,0.00058365666,0.000021568982,0.000055146396,0.00023383241,0.00009499739,0.00026931093,0.0007647143,0.9726554,0.000004908244,0.00035511027,0.018656861],"study_design_scores_gemma":[0.002652384,0.007880163,0.00019510246,0.000040083156,0.00003401204,0.000009378041,0.000071591276,0.0007778758,0.98443896,0.00004383305,0.00326969,0.00058691506],"about_ca_topic_score_codex":0.00011536279,"about_ca_topic_score_gemma":0.00018535097,"teacher_disagreement_score":0.018069945,"about_ca_system_score_codex":0.00026213992,"about_ca_system_score_gemma":0.00055297493,"threshold_uncertainty_score":0.999697},"labels":[],"label_agreement":null},{"id":"W4388570838","doi":"10.1016/j.omto.2023.100748","title":"Kinetic analysis of oncolytic OrfV-induced innate and adaptive immune responses in a murine model of late-stage ovarian cancer","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada; Cancer Research Society; University of Guelph","keywords":"Oncolytic virus; Immune system; Immunotherapy; Tumor microenvironment; Acquired immune system; Biology; Innate immune system; Ovarian cancer; Effector; Cancer research; Immunology; Immunity; Cancer immunotherapy; Cancer","score_opus":0.05008230310842119,"score_gpt":0.3473167769884998,"score_spread":0.29723447388007856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388570838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967426,0.0017163274,0.0005091087,0.00017914035,0.000028563301,0.0005390873,0.0001546216,0.000017174874,0.000113349925],"genre_scores_gemma":[0.99526256,0.0032549594,0.00034411528,0.00014489371,0.000016654176,0.0000893571,0.00006937387,0.00006487587,0.0007532147],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9977394,0.00030497526,0.0006017921,0.0005070419,0.0004115005,0.0004353451],"domain_scores_gemma":[0.9986136,0.0000653038,0.00024666608,0.00073180016,0.00023570133,0.00010694321],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078247895,0.0002870278,0.0006452538,0.00082372833,0.000041614392,0.000015424845,0.00035729836,0.00023519725,0.000029875715],"category_scores_gemma":[0.00009246996,0.0002861631,0.00022713497,0.0020018592,0.0001744596,0.000006675596,0.00018283972,0.00019933433,0.0000017157708],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005739307,0.00016129109,0.0007224737,0.000031220487,0.0010871142,0.000031253112,0.000352659,0.11062348,0.8772953,0.000053548025,0.0000048309703,0.0038974967],"study_design_scores_gemma":[0.0025537002,0.0025036547,0.0041485513,0.000039522773,0.00014186683,5.3880257e-7,0.000104706574,0.17100349,0.8190631,0.00008951329,0.00007971735,0.00027160876],"about_ca_topic_score_codex":0.00041261956,"about_ca_topic_score_gemma":0.0007236134,"teacher_disagreement_score":0.060380004,"about_ca_system_score_codex":0.00007214213,"about_ca_system_score_gemma":0.00045524814,"threshold_uncertainty_score":0.99995905},"labels":[],"label_agreement":null},{"id":"W4389274134","doi":"10.1016/j.omto.2023.100754","title":"Gaining insights into virotherapy with canine models","year":2023,"lang":"en","type":"article","venue":"Molecular Therapy — Oncolytics","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université de Sherbrooke","funders":"Université de Sherbrooke","keywords":"Oncolytic virus; Vesicular stomatitis virus; Osteosarcoma; Medicine; Oncology; Internal medicine; Context (archaeology); Cancer; Virotherapy; Cancer research; Virus; Immunology; Biology","score_opus":0.027806610463852466,"score_gpt":0.3065705279593866,"score_spread":0.27876391749553414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389274134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98391616,0.002799755,0.010298856,0.00047325715,0.000080938284,0.0006701947,0.0000067708042,0.00013962551,0.0016144376],"genre_scores_gemma":[0.9903595,0.004088078,0.0010777555,0.0021542732,0.00022996211,0.00017961531,0.00019330393,0.00021561728,0.0015019086],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99751264,0.00019890143,0.00030534022,0.00071131985,0.0006129305,0.0006588727],"domain_scores_gemma":[0.9984478,0.000025713918,0.00010213979,0.0009883886,0.00020358726,0.00023241872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003627975,0.0004098072,0.00031835353,0.000228808,0.00021897108,0.00008034261,0.000565257,0.00024903534,0.000037323567],"category_scores_gemma":[0.000018025283,0.00035224066,0.00014925806,0.0007710738,0.00018634992,0.000012147419,0.00011504517,0.0002501787,0.000077281424],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027560387,0.00011816462,0.0001051265,0.000012843321,0.00031432282,0.00013529646,0.00067471055,0.022184376,0.95556855,0.00021001925,0.0004934572,0.017427068],"study_design_scores_gemma":[0.0038346616,0.008297502,0.00006977174,0.000035343626,0.000015235944,0.000016839624,0.00019428336,0.010401341,0.940768,0.001899414,0.03376471,0.00070288236],"about_ca_topic_score_codex":0.000046424273,"about_ca_topic_score_gemma":0.00022915177,"teacher_disagreement_score":0.033271253,"about_ca_system_score_codex":0.00007603686,"about_ca_system_score_gemma":0.00038660932,"threshold_uncertainty_score":0.99989295},"labels":[],"label_agreement":null}]}